Metamason draws $3M in funding
LOS ANGELES – Metamason, the company behind a 3-D scanned and printed customized CPAP mask, has closed on a $3 million Series Seed financing round. The investment was led by 3P Equity Partners, a manufacturing-focused private equity firm in San Jose, Calif., and Tsing Capital, a leading “cleantech” venture capital firm in China. “We are thrilled to reach this important milestone for the company,” said CEO Leslie Oliver Karpas. “Our investors are confident that Metamason will be a disruptive, positive force in the $4 billion global sleep apnea market.” Metamason plans to use the investment to complete regulatory clearance with the U.S. Food and Drug Administration and to run initial clinical trials for its patent-pending flagship product, Respere. Also on the horizon: a crowdfunding campaign later in 2016 and marketing activities in early 2017. Metamason expects to make Respere publicly available in the second quarter of 2017.